UGNE: Conference call regarding To Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics @ 09:00 ET Toda

Posted on: Wed, 21 Oct 2009 02:29:00 EDT


Symbols: UGNE
Ridgeland, MS, OCT 21, 2009 (EventX/Knobias.com via COMTEX) --
UGNE | Quote | Chart | News | PowerRating -- Unigene Labs Inc (OTCBB : UGNE | Quote | Chart | News | PowerRating) will host a conference call regarding To Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics.Call Details

    When     : Wednesday, October 21, 2009
Webcast : Click Here to Listen
Phone # : 877-407-0782
Intl # : 201-689-8567

Replay Information

    Phone #  : 877-660-6853
Intl # : 201-612-7415

Source: Company Press ReleaseMisc Information: A replay will be available for seven days after the call. The conference call may also be accessed via the Web at http://www.unigene.com; a link will be provided for listeners to join the call.

GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by at least 10 minutes. To get all Knobias alerts in real-time daily, visit http://www.knobias.com/cmtx

ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.

Knobias.com, LLC
601-978-3399
601-978-3675
info@knobias.com
www.knobias.com/cmtx

For full details on (UGNE) UGNE. (UGNE) has Short Term PowerRatings at TradingMarkets. Details on (UGNE) Short Term PowerRatings is available at This Link.